Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000902664-25-002613
Filing Date
2025-06-02
Accepted
2025-06-02 17:22:46
Documents
1
Period of Report
2025-05-29

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 6391
  Complete submission text file 0000902664-25-002613.txt   8564
Mailing Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502
Business Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502 6508377000
EXELIXIS, INC. (Issuer) CIK: 0000939767 (see all company filings)

EIN.: 043257395 | State of Incorp.: DE | Fiscal Year End: 0102
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 780 THIRD AVENUE 30TH FLOOR NEW YORK NY 10017
Business Address 780 THIRD AVENUE 30TH FLOOR NEW YORK NY 10017 718-570-6018
Caligan Partners LP (Reporting) CIK: 0001727492 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-30235 | Film No.: 251016161

Mailing Address 780 THIRD AVENUE 30TH FLOOR NEW YORK NY 10017
Business Address
JOHNSON DAVID EDWARD (Reporting) CIK: 0001785557 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30235 | Film No.: 251016162